DVA
NYSE DaVita Inc.$175.19 ↑ +0.00 (+0.00%) Trading Up from the previous close of $175.19, $1.79 below the day’s high of $176.98
- YTD change
- +54.20%
- vs 20-day SMA
- -3.86%
- vs 200-day SMA
- +3.69%
Price ranges
Price & Performance
+22.82 (+14.98%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 29.2% away from all-time highs of $247.49
- DVA is up 54% since the beginning of the year
- DVA is up 34% over the past 12 months
- DVA is down 3% over the past 1 month
- 7% of all DVA investors are betting against DVA
- Number of investors short DVA has gone up 1% versus last month
DVA reads not so good: price sits above one of the two key moving averages, short interest is rising month over month, the 12-month move is +31.9%.
- Previous minute
- +$0.22
- Last hour
- +$0.70
- Last 5 days
- -3.92%
- vs 8-day SMA
- -3.17%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.